Travere Therapeutics, Inc. · NASDAQ:TVTX
Inrig Jula sold 22,485 Travere Therapeutics, Inc. shares (Form 4)
Traded May 4 to May 6, 2026 · Filed May 6, 2026
From May 4 to May 6, 2026, Inrig Jula (CHIEF MEDICAL OFFICER) sold 22,485 Travere Therapeutics, Inc. shares at an average US$45.15 for US$1.02M under a trading plan, leaving 113,238 shares. Filed May 6, 2026 (Form 4).
- Sold
- 22,485 shares
- Price
- US$45.15 average (US$43.95 to US$46.65)
- Value
- US$1.02M
- Holding after
- 113,238 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF MEDICAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Option exercise | 20,000 | US$22.40 | 131,473 | Direct |
| May 4, 2026 | Common Stock | Sale | 20,000 | US$45.00 | 111,473 | Direct |
| May 4, 2026 | Common Stock | Option exercise | 4,250 | 115,723 | Direct | |
| May 5, 2026 | Common Stock | Sale | 2,174 | US$46.65 | 113,549 | Direct |
| May 6, 2026 | Common Stock | Sale | 311 | US$43.95 | 113,238 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Inrig Jula
- Travere Therapeutics, Inc. shareholders
- Form 4 · Inrig Jula · Sep 17, 2026
- Form 4 · Inrig Jula · Jun 22, 2026
- Form 4 · Inrig Jula · Apr 15, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026